StockUS listing USDOCSNYSEHealthcareQuality Compounder

Doximity Inc(DOCS) Stock Analysis | Healthcare

USD --+0.00%
Reward71High
Risk45Moderate
75%Data
Strong 25% profit margin
USD —+0.00 (+0.00%) Previous close · NYSE
Market cap 5.52Bn
Reward Ratingⓘ71 High reward assessment · 75% data coverage
Top 25% of stocksView factors
Risk Ratingⓘ45 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on DOCS to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Doximity Inc?

operates a digital platform for medical professionals in the United States.

AI Brief Pro

The brief on Doximity Inc

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Doximity Inc?

operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 5.52B, and a P/E ratio of 36.4x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Strong margins and consistent earnings support financial stability.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: High (71)
Company Information
SectorHealthcare
IndustryHealth Information Services
P/E Ratio36.4353
Beta1.216
Insider Activity
12M windowBearish
Shares soldShares bought
0-3months
0
0
3-6months
0
0
6-9months
49,028 shares
$226k
0
9-12months
12,000 shares
$133k
0